Myriad Genetics Inc (MYGN) — 10-Q Filings
All 10-Q filings from Myriad Genetics Inc. Browse 7 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (7)
- 10-Q Filing — May 6, 2026
-
Myriad Genetics Plunges to $358M Loss on Massive Goodwill Impairment
— Nov 4, 2025 Risk: high
MYRIAD GENETICS INC (MYGN) reported a significant net loss of $358.0 million for the nine months ended September 30, 2025, a substantial increase from the $84.8 -
Myriad Genetics Narrows Losses on Strong Q2 Revenue Growth
— Aug 6, 2025 Risk: medium
MYRIAD GENETICS INC reported a net loss of $10.1 million for the three months ended June 30, 2025, a significant improvement from the net loss of $20.3 million -
Myriad Genetics Files Q1 2025 10-Q Report
— May 7, 2025 Risk: medium
Myriad Genetics Inc. filed its 10-Q report for the period ending March 31, 2025. The filing includes financial data and operational updates for the first quarte -
Myriad Genetics Files Q3 2024 10-Q
— Nov 8, 2024 Risk: medium
Myriad Genetics Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the fiscal year. -
Myriad Genetics Q2 2024 Update
— Aug 7, 2024 Risk: medium
Myriad Genetics Inc. reported its second quarter 2024 results, ending June 30, 2024. The company's financial performance for the quarter and the first half of t -
Myriad Genetics Inc. Files 10-Q for Period Ending March 31, 2024
— May 8, 2024 Risk: medium
MYRIAD GENETICS INC (MYGN) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Myriad Genetics Inc. filed a 10-Q report for the period ending March 31,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX